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Abstract
Background: Traumatic brain injury (TBI) is a heterogeneous syndrome with a broad range of outcome. We
developed a simple model for long-term outcome prognostication after severe TBI.
Methods: Secondary data analysis of a large multicenter randomized trial. Patients were grouped according to 6-month
extended Glasgow outcome scale (eGOS): poor-outcome (eGOS≤ 4; severe disability or death) and acceptable outcome
(eGOS > 4; no or moderate disability). A prediction decision tree was built using binary recursive partitioning to predict
poor or acceptable 6-month outcome. Comparison to two previously published and validated models was made.
Results: The decision tree included the predictors of head Abbreviated Injury Scale (AIS) severity, the Marshall computed
tomography score, and pupillary reactivity. All patients with a head AIS severity of 5 were predicted to have a poor
outcome. In patients with head AIS severity < 5, the model predicted an acceptable outcome for (1) those with Marshall
score of 1, and (2) those with Marshall score above 1 but with reactive pupils at admission. The decision tree had a
sensitivity of 72.3 % (95 % CI: 66.4–77.6 %) and specificity of 62.5 % (95 % CI: 54.9–69.6 %). The proportion correctly
classified for the comparison models was similar to our model. Our model was more apt at correctly classifying those
with poor outcome but more likely to misclassify those with acceptable outcome than the comparison models.
Conclusion: Predicting long-term outcome early after TBI remains challenging and inexact. This model could be useful
for research and quality improvement studies to provide an early assessment of injury severity, but is not sufficiently
accurate to guide decision-making in the clinical setting.
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Background
Traumatic brain injury (TBI) remains the leading cause
of death and significant disability after severe blunt
trauma [1]. It is estimated that 3.2 million people in the
American continent live with disabilities caused by TBI
[2]. Annually, the cost of TBI amounts to more than $35
billion in the United States alone [3–5].
In severe TBI, more than in any other injury, the pre-
occupation with long-term functional neurological out-
come permeates many of the early decisions and
interventions offered to these patients. Traumatic brain
injury consists of a heterogeneous group of patients and
injuries, in whom individual neurological recovery is
difficult to predict at any time, but particularly early
after admission. Accurate and useful prediction models
to estimate neurological recovery is few and most only
applicable when used days after the injury [6, 7]. The
ability to reliably predict neurological recovery early
could allow customization of medical decisions for
physicians and families during initial resuscitation, from
diagnosis to interventions. It could also reduce unwar-
ranted decisions to withdraw life-supporting measures
due to the perception of unfavorable neurological recov-
ery [8, 9], help stratify patients into protocols and
clinical trials, and assist with quality evaluation and
improvement programs among many other utilities.
A variety of scales and models have been used to
predict outcome after TBI, with many limitations besides
not being applicable early after admission [6, 7]. Ana-
tomic injury scales, such as Injury Severity Score (ISS)
and the Abbreviated Injury Scale (AIS) are widely
adopted predictors of trauma outcome. These scales are
calculated by trained technicians and help convey the
threat to life but fail to discriminate long-term neuro-
logical outcome. The simpler, easy to remember and
vastly adopted Glasgow Coma Scale (GCS) [10] is also
associated with mortality but not functional outcome.
Other models have been criticized for being developed
using small sample sizes, single center samples, lacking
validation and for not being practical for use during
early resuscitation [6, 7]. Some of these limitations were
overcome by recent prognostic models developed
through the IMPACT (International Mission for Progno-
sis and Analysis of Clinical Trials in TBI) [11] and
CRASH (Corticosteroid Randomization After Significant
Head Injury) [2] studies. These models were developed
on large data sets and have good discriminatory power
to predict neurological outcome at 6 months. The com-
plexity of these models varies, and the calculations
utilize clinical features, imaging and laboratorial mea-
surements available soon after admission.
Using data from a recently completed, large, multicen-
ter, double-blinded, randomized, placebo-controlled clin-
ical trial [1], we developed a prognostic model for severe
TBI using computed tomography (CT) scan and other
readily available early parameters. To this end, we used
recursive partitioning to build an easily interpretable
model that predicts neurological outcome at 6 months
using a limited number of patient characteristics avail-
able soon after injury.
Methods
Study design and setting
This study is a secondary analysis of data from a multi-
center, double blind, randomized, placebo-controlled
clinical trial conducted by the Resuscitation Outcomes
Consortium between May 2006 and May 2009 (clinical-
trials.gov Identifier: NCT00316004). The trial involved
114 North American emergency medical services agen-
cies and was conducted in two cohorts of patients: those
with hypovolemic shock secondary to blunt or penetrat-
ing trauma and those with severe blunt TBI. This study
is restricted to the second cohort of patients with severe
blunt TBI. The objective of the trial in this cohort was
to determine whether administering hypertonic fluids in
the pre-hospital setting could improve long-term neuro-
logic outcome as measured by 6-month eGOS. Add-
itional details about the trial are available elsewhere [1].
Population
The trial included patients aged 15 years or older with
blunt trauma and severe TBI defined as a pre-hospital
GCS of 8 or less who were determined to not be in
hypovolemic shock. For this study, we excluded those
patients who died within 24 h of emergency department
(ED) admission, since this is a different population from
long-term survivors, and the goal of this analysis was to
predict outcome at 6-month. We also excluded patients
with unknown survival status at 24 h, those without a
blunt injury, and those who did not have a head CT.
Outcome
The outcome of interest was the patient’s functional
neurological status at 6 months post-injury, which we
quantified using 6-month eGOS. Extended GOS was col-
lected through a structured telephone survey of patients;
a family member or caregiver was allowed to respond
when the patient was unable to complete the survey. As
in the original trial, we classified patients on the basis of
whether they had a poor outcome (eGOS ≤ 4; severe
disability or death) or an acceptable outcome (eGOS > 4;
no or moderate disability). The primary analysis of this
trial [1] used imputed 6-month eGOS as the outcome
for patients missing 6-month eGOS. Similarly, those
with missing 6-month eGOS in our study were assigned
their average imputed eGOS from the primary analysis
of the trial. The imputations were done using multiple
hot deck imputations with 20 imputations [1].
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Predictors
In building our predictive model, we were interested in
considering patient information collected upon arrival to
ED including the results of the first head CT scan. The
predictors we considered were pupil reactivity at ED
admission (none, 1, or 2 reactive pupils), first systolic
blood pressure (SBP) measurement in the ED, age, sex,
Marshall score from the first head CT (measured on a
scale from 1 to 6) [12], first GCS motor score in the ED,
the head AIS severity (measured on a scale from 0 to 6),
and the head AIS category. Head AIS scores were sorted
into head AIS categories based on the region and type of
injury. These categories include brainstem, cerebellar,
contusion, diffuse, epidural, intraventricular hemorrhage
(IVH), subarachnoid hemorrhage (SAH), and subdural
hematoma (SDH). Each patient was classified as having
or not having an injury for each of these categories. No
requirement as to the severity of the injury was made as
the minimum severity of a clinically important injury
may vary between categories. As mentioned previously,
this model was developed excluding patients who died
within 24 h. Therefore, this rule would only be applic-
able ≥ 24 h.
Statistical analysis
We used descriptive statistics to compare patient charac-
teristics between those with a poor 6-month outcome
(eGOS ≤ 4) and an acceptable 6-month outcome
(eGOS > 4). Additionally, we considered how eGOS var-
ied across observed combinations of Marshall score [12]
and head AIS severity.
Our predictive model took the form of a decision tree
[13], in which the patient population was repeatedly split
on the basis of predictors into groups that were more
and more homogeneous with respect to 6-month out-
come (eGOS ≤ 4 or > 4). We used binary recursive parti-
tioning to derive the decision tree(13). The tree
classified patients into poor or acceptable 6-month out-
come (eGOS ≤ 4 or > 4) based on patient characteristics
collected soon after ED admission and the results of the
first head CT scan. Recursive partitioning is useful when
there are many potential complex interactions between
the predictors of interest.
Observations were randomly split into training and
validation sets, which contained 60 and 40 % of the ob-
servations respectively. The model was fit using the
training set and the optimal size of the tree (i.e. number
of splits) was determined using 10-fold cross-validation
with the optimal tree of a given size being that which
minimized the classification error, the proportion of pa-
tients whose predicted outcome status (eGOS ≤ 4 or > 4)
was incorrect.
Two different techniques for handling missingness of
the predictors were used: single imputation and surrogate
splits. Single imputation was used, in lieu of multiple
imputations, due to the difficulty of obtaining a single,
simple decision rule when using multiple imputations.
Alternatively, surrogate splits is a technique where a vari-
able that is highly correlated with the splitting variable is
used when the splitting variable is missing. Missingness of
the outcome was handled through assigning patients their
average imputed eGOS as described above.
The decision tree was evaluated in the separate valid-
ation set, which contained the remaining 40 % of
patients in our data set. We calculated sensitivity, speci-
ficity, positive predictive value, negative predictive value,
and percent correctly classified, as well as 95 % confi-
dence intervals for each of these. These measures were
compared to those obtained from using two previously
validated models to predict 6-month outcome (eGOS ≤ 4
or > 4) after TBI, which were derived using data from 11
different studies and validated using data from the
Medical Research Council CRASH Trial. We specifically
compared to the core model, which incorporated age,
GCS motor score, and pupil reactivity, and the extended
model, which additionally incorporated hypotension
status, hypoxia status, Marshall score, presence of trau-
matic subarachnoid hemorrhage, and presence of
epidural hematoma. Both models provided predicted
probabilities of eGOS ≤ 4. We dichotomized the predic-
tions based on whether or not the predicted probabilities
were above a certain threshold, which was chosen to be
the threshold that maximized the percent correctly
classified in the training set. Lastly, we compare the
three models using receiver operating characteristic
(ROC) curves, which illustrate the performance of the
models for all possible thresholds for dichotomizing the
predicted probabilities of the outcome. All statistical
analyses were performed using R version 3.0.2 and the
rpart library version 4.1–8.
Results
Descriptive statistics
Of the 1282 patients enrolled in the TBI cohort of the
trial, 1089 patients were included in our analysis with 193
(15 %) of those enrolled being excluded due to death
within 24 h of ED admission, unknown 24-h survival sta-
tus, no blunt injury, and no head CT (Fig. 1). Of those
with non-missing eGOS, 456 (50 %) had a poor 6-month
outcome (eGOS ≤ 4). There were 181 patients (17 %) with
a missing eGOS – 90 % of these had an average imputed
eGOS above 4. Thus including those with imputed eGOS,
43 % of patients in our analysis had a poor 6-month
outcome.
Table 1 compares characteristics of predictors be-
tween those with poor versus acceptable 6-month
eGOS (≤4 or > 4). The most striking differences between
the two groups were related to higher head AIS and
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Marshall scores and absence of pupillary reactivity among
those with a poor neurological outcome (eGOS ≤ 4).
Table 2 compares the mean 6-month eGOS across the
observed combinations of Marshall score and head AIS
severity. There were no patients with a head AIS severity
of 6 in our analysis population. Note that the imputed
eGOS was used for those missing eGOS, however those
with missing Marshall score or head AIS severity were
excluded (n = 16). Those patients with a Marshall score
of Diffuse Injury I tended to do well at 6 months
(eGOS > 4), regardless of their head AIS severity. Aside
from that, 6-month outcomes tended to worsen with
higher head AIS severities and higher Marshall scores.
The predictors of age, sex, first ED SBP, and head AIS
categories do not have any missing data. The other
predictors had limited amounts of missingness: first ED
GCS motor (0.2 % missing), head AIS severity (1.5 %),
Marshall score (0.1 %), and pupil reactivity (4.3 %).
Overall, 94.2 % of patients had no missing data for any
of the predictors.
Decision tree selection
The final decision tree is included in Fig. 2. All patients
with a head AIS severity of 5 were predicted to have a
poor outcome (eGOS ≤ 4). Among those with a head
AIS severity less than 5, the tree predicts an acceptable
outcome (eGOS > 4) for two groups of patients: (1) those
with a Marshall score of 1, and (2) those with a Marshall
score above 1 but with reactive pupils at ED admission.
Note that the trees selected were identical whether
surrogate splits or single imputation was used to address
the missingness of predictors.
Decision tree validation
In Table 3, we present the classification performance of
the proposed decision tree on the validation data set
[13]. The results presented correspond to using the sin-
gle imputation models from the training set to impute
any missing predictors in the validation data set. How-
ever, the results from using surrogate splits to handle
missingness were very similar. We also present the pro-
portion of patients in each final category of the decision
tree, as well as the percent of false positives or negatives,
for the validation data set in Fig. 2. Additionally, we
present the performance results in comparison to the
previously validated models from in Table 3 [11]. The
proportion correctly classified for these models is similar
to our proposed model, while our model has higher spe-
cificity (our model vs. core: p = 0.007; extended: p =
0.001) and lower sensitivity (our model vs. core: p =
0.002; extended: p < 0.001) than the comparison models.
This is consistent with our model being more apt at cor-
rectly classifying those with a poor outcome (eGOS ≤ 4),
but more likely to misclassify those who in truth have an
acceptable outcome (eGOS > 4).
While the results for Table 3 correspond to dichotom-
izing predicted probabilities based on a specific thresh-
old, we can also consider the performance for any
threshold and plot the corresponding sensitivity and
specificity in a ROC curve. The ROC curves for the
Fig. 1 The refinement of the trial population to the analysis population. *Nine of these patients had unknown survival status as they
refused consent
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three models are shown in Fig. 3. The proposed model
performed the best in comparison to the two other
models when thresholds for dichotomization were
chosen to favor high specificity over high sensitivity. The
area under the curve (AUC) for our proposed model
was 0.67 (95 % CI: 0.63–0.72). The AUCs for the com-
parison models of core and extended were 0.66 (95 %
CI: 0.61–0.70) and 0.69 (95 % CI: 0.66–0.73), respect-
ively. Comparing our model to the previously published
models, our model had an AUC that was 0.016 higher
(95 % CI:−0.034–0.066; p = 0.52) than the core model
and 0.011 lower (95 % CI:−0.034—0.056; p = 0.63) than
the extended model.
Discussion
Early management of patients with severe TBI is among
the most challenging issues in trauma. Traumatic brain
injury is the leading cause of death, but more relevant to
this work is that up to 50 % of those with severe TBI will
have long-term sequelae and up to 30 % develop devas-
tating long-term neurological deficits. Furthermore, it is
notoriously difficult to identify patients that will have a
poor neurological recovery during the early phases of re-
suscitation [14–18]. We found that a decision tree
approach could predict with acceptable certainty, which
patients with severe blunt TBI will have a poor or ac-
ceptable 6-month neurological outcome.
The model was developed using a population of 1089
patients with severe TBI enrolled in a recently com-
pleted randomized controlled trial. Forty-three percent
of the patients had a poor 6-month outcome (eGOS ≤ 4).
A decision tree built using binary recursive partitioning
[13] was used considering its usefulness in situations
where many potential complex interactions occur, as
expected in this population. The final decision tree
included the three predictors of head AIS severity,
Marshall score, and pupil reactivity, which were selected
as a part of the recursive partitioning process from eight
different potential predictors available shortly after ED
arrival.





Age (years) 42 (19) 34 (15)
Gender: Male 351 (74 %) 486 (79 %)
SBP, first ED measurement 141 (33) 142 (25)
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Diffuse Injury I (no visible pathology)
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Diffuse Injury III (swelling)































aSummaries include: mean (standard deviation) for continuous variables and
n (%) for binary variables
Average imputed 6-month eGOS used for those missing eGOS
Table 2 Mean eGOS for different combinations of head AIS severity and Marshall score with number of patients per cell indicated in
















No injury (Score of 0) 6.1 (184) 4.1 (18) 1.7 (3) NA 5.9 (2) 2.0 (4)
Minor (Score of 1) 5.8 (6) NA NA NA NA NA
Moderate (Score of 2) 7.0 (106) 4.7 (3) 1.0 (1) 4.0 (1) 3.0 (1) NA
Serious (Score of 3) 6.6 (38) 5.6 (92) 5.5 (16) NA 4.2(6) 8.0 (1)
Severe (Score of 4) 5.2 (8) 5.5 (172) 4.3 (35) 4.4 (9) 3.3 (27) 1.0 (3)
Critical (Score of 5) 5.0 (15) 4.1 (134) 3.2 (65) 2.6 (20) 2.7 (100) 1.0 (3)
Rizoli et al. BMC Emergency Medicine  (2016) 16:32 Page 5 of 9
The decision tree predictive model we developed is
simple, easy-to-remember, constructed on the first head
CT scan and admission characteristics, and is capable of
predicting the likelihood of unfavorable outcome at
6 months. It starts by determining whether the patient
with severe TBI has an AIS head score of 5. The head
AIS severity of 5 is bestowed to patients alive with large
(>1 cm thick) subdural or epidural hematomas or
massive/extensive intra cerebral hemorrhage or contu-
sions. The presence of a head AIS severity of 5 is associ-
ated with poor 6-month functional neurological
outcome (eGOS ≤ 4). For the patients with head AIS se-
verity less than 5, we split patients into those with a
Marshall score of 1 and those with a score greater than
1. The Marshall score of 1 is defined as a head CT scan
with no visible pathology, and these patients are pre-
dicted to have an acceptable 6-month outcome. For
those with any abnormality on the head CT scan
(Marshall score >1), the next and final predictive factor
is the presence of bilateral reactive pupils, which is asso-
ciated with acceptable outcome versus poor outcome if
one or both pupils are not reactive.
The three prognostic indicators: anatomical head in-
juries scored by the AIS, head CT scan and pupil reactiv-
ity [16] have been used in other predictive models. The
final head AIS severity is rarely estimated in the first
Fig. 2 Decision tree for predicting poor (6-month eGOS≤ 4) or acceptable (6- month eGOS > 4) neurological outcome for TBI patients. The percent of
patients falling into each category, as well as the false positive or negative rate, is indicated for the validation data set. Note that our model applies
only to those with a head AIS severity of 5 or lower, as our study population did not include any patients with a head AIS severity of 6
Table 3 Summary accuracy measures in the validation sample for our proposed model and two of the models proposed in [2]a
Our proposed model
Estimate (95 % confidence interval)
Previously validated core model
Estimate (95 %
confidence interval)
Previously validated extended model
Estimate (95 % confidence interval)
Sensitivity 72.3 % (66.4–77.6 %) 83.8 % (78.7–88.0 %) 92.7 % (88.6–95.4 %)
Specificity 62.5 % (54.9–69.6 %) 47.7 % (40.2–55.4 %) 44.3 % (36.9–52.0 %)
Positive predictive value 74.0 % (68.1–79.2 %) 70.3 % (64.8–75.3 %) 71.1 % (65.9–75.8 %)
Negative predictive value 60.4 % (52.9–67.5 %) 66.7 % (57.6–74.7 %) 80.4 % (70.9–87.5 %)
Correct classification 68.3 % (63.7–72.6 %) 69.3 % (64.7–73.5 %) 73.2 % (68.7–77.2 %)
aIn calculating these measures, we used ‘positive’ to denote an acceptable outcome (eGOS > 4)
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hours following hospital admission, as well as the defini-
tive radiology interpretation of the head CT scan, that in
many trauma centers is only available the following day.
Nevertheless, the presence of extensive anatomical injur-
ies to the head (AIS severity of 5), the identification of
head CT scan as having no visible pathology (Marshall
score of 1) and pupil reaction are consistently sought
and recognized by clinicians during resuscitation, and
used to make medical decisions. Thus the expectation is
that clinicians with some experience in trauma resuscita-
tion would have no difficulties in using this predictive
model in practice.
The predictive model has a good discrimination between
patients with poor and acceptable outcome. The internal
validation was performed in a separate set of patients con-
taining 40 % of all patients from our data set. The percent
correctly classified (Table 3) was similar to two predictive
models described by Steyerberg et al. [11] Relative to the
comparison models, our model had a higher specificity, i.e.
was more apt at correctly classifying those with poor out-
come, but a lower sensitivity, i.e. more likely to misclassify
those with acceptable outcome. The choice to compare our
model to these two other predictive models comes from
the fact that those models are similar to ours in aiming to
prognosticate 6-month outcomes after severe TBI using
readily available indicators that have been validated. Our
model differs from theirs in that it is not designed to
predict mortality, consists of a simple decision tree while
theirs are developed using logistic regression and our pre-
dictions are readily available without requiring calculations
or some form of computer support.
Any predictive model must be used with caution, in
particular decision-making for individual patients. A
recent Canadian multicenter cohort study [9] demon-
strated that most deaths after severe TBI (45 to 86.8 %)
were due to withdrawal of life-supporting measures,
often based on perception of unfavorable chances of
meaningful neurological recovery. A significant propor-
tion of the deaths due to withdrawal occurred early,
within 3 days of injury, and varied significantly by center
(odds ratios varied between 0.42 and 2.4, p = 0.0001).
The expressed caution from this study was that young
and otherwise healthy TBI patients might have their life
supporting measures needlessly withdrawn due to the
perception of unfavorable neurological outcomes. In
relation to our findings, our model had a lower sensitiv-
ity than the two previously validated models. That is, a
smaller portion of those with acceptable 6-month out-
comes were identified correctly using our model. This
could have detrimental effects in the clinical setting if
our model was used as justification for withdrawal of life
support or further interventions. Thus we caution
against using this model to guide decision-making in the
clinical setting, as it is not yet accurate enough.
Fig. 3 ROC curves comparing the performance in the validation set of the proposed model with two previously validated models. Sensitivity is
the proportion of those with an acceptable outcome who were correctly predicted to have an acceptable outcome. Specificity is the proportion
of those with a poor outcome who were correctly predicted to have a poor outcome
Rizoli et al. BMC Emergency Medicine  (2016) 16:32 Page 7 of 9
The present study has several limitations. The ori-
ginal study was designed to study the effect of pre-
hospital administration of hypertonic fluids on the
long-term (6-month) neurological outcome of patients
with severe TBI without hypovolemic shock. While it
should be noted, it is improbable that the administra-
tion of hypertonic fluids affected the neurological out-
come and the development of the predictive model.
Few variables and values were missing, as detailed in
the results. Two different techniques for handling miss-
ingness were used, single imputation and surrogate
splits. While these techniques are warranted, missing-
ness remains another limitation.
Conclusion
Predicting long-term neurological recovery early after head
injury remains a major challenge. Using data from a large
multicenter randomized controlled trial, we analyzed 1089
adult patients with severe TBI, no evidence of hemorrhagic
shock and with at least a head CT scan performed. We
then developed a prognostic decision tree capable of dis-
criminating patients with poor or acceptable 6-month func-
tional neurological outcome (eGOS ≤4 or >4). The decision
tree prognostic model uses 3 indicators commonly sought
and used by practicing clinicians during early resuscitation
of patients with severe TBI: the extent of anatomical dam-
age to the head (head AIS severity), the initial head CT scan
(Marshall score) and pupil reactivity. This early predictive
model could be useful for research and quality improve-
ment, but caution should be exercised when using it for
clinical decision-making.
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